| Literature DB >> 24644045 |
Veronika Fedirko1, Talita Duarte-Salles, Christina Bamia, Antonia Trichopoulou, Krasimira Aleksandrova, Dimitrios Trichopoulos, Elisabeth Trepo, Anne Tjønneland, Anja Olsen, Kim Overvad, Marie-Christine Boutron-Ruault, Françoise Clavel-Chapelon, Marina Kvaskoff, Tilman Kühn, Annie Lukanova, Heiner Boeing, Brian Buijsse, Eleni Klinaki, Chrysanthi Tsimakidi, Alessio Naccarati, Giovanna Tagliabue, Salvatore Panico, Rosario Tumino, Domenico Palli, H Bas Bueno-de-Mesquita, Peter D Siersema, Petra H Peters, Eiliv Lund, Magritt Brustad, Karina Standahl Olsen, Elisabete Weiderpass, Raul Zamora-Ros, María-José Sánchez, Eva Ardanaz, Pilar Amiano, Carmen Navarro, J Ramón Quirós, Mårten Werner, Malin Sund, Björn Lindkvist, Johan Malm, Ruth C Travis, Kay-Tee Khaw, Magdalena Stepien, Augustin Scalbert, Isabelle Romieu, Pagona Lagiou, Elio Riboli, Mazda Jenab.
Abstract
UNLABELLED: The association between vitamin D status and hepatocellular carcinoma (HCC) has not been well investigated, despite experimental evidence supporting an important role of vitamin D in liver pathophysiology. Our objective was to investigate the association between prediagnostic circulating 25-hydroxyvitamin D [25(OH)D] serum levels and the risk of HCC in a prospective, nested case-control study among 520,000 participants in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Each case (n = 138) diagnosed between 1992 and 2010 was matched to one control by age, sex, study center, date and time of blood collection, and fasting status. Serum baseline levels of 25(OH)D were measured by liquid chromatography/tandem mass spectrometry. Multivariable incident rate ratios (IRRs) of HCC associated with continuous (per 10 nmol/L) or categorical levels (tertiles or a priori-defined categories) of prediagnostic 25(OH)D were calculated using conditional logistic regression. Higher 25(OH)D levels were associated with a 49% reduction in the risk of HCC (highest versus lowest tertile: multivariable IRR = 0.51, 95% confidence interval [CI], 0.26 to 0.99; Ptrend = 0.04; per 10 nmol/L increase: IRR = 0.80, 95% CI, 0.68-0.94). The finding did not vary substantially by time from enrolment to diagnosis, and did not change after adjustment for biomarkers of preexisting liver damage, nor chronic infection with hepatitis B or C viruses. The findings were not modified by body size or smoking status.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24644045 DOI: 10.1002/hep.27079
Source DB: PubMed Journal: Hepatology ISSN: 0270-9139 Impact factor: 17.425